C.R. Bard (BCR) Stock Price, News & Analysis

Company Overview

C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Key Stats

• Today's Range: $331.24 to $331.24
• 50-Day Range: N/A
• 52-Week Range: $222.42 to $337.73
• Volume: N/A
• Average Volume: 679,456 shs
• Market Capitalization: N/A
• P/E Ratio: 21.91
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BCR Stock Analysis - Frequently Asked Questions

How were C.R. Bard's earnings last quarter?

C.R. Bard Inc (NYSE:BCR) released its quarterly earnings results on Wednesday, October, 25th. The medical instruments supplier reported $3.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.96 by $0.06. The company's quarterly revenue was up 5.1% compared to the same quarter last year.

What other stocks do shareholders of C.R. Bard own?

Based on aggregate information from My MarketBeat watchlists, some other companies that C.R. Bard investors own include Becton, Dickinson and Company (BDX), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), AbbVie (ABBV), Baxter International (BAX), Boston Scientific (BSX) and Johnson & Johnson (jnj).

Company Calendar

• Last Earnings: 10/25/2017
• Today: 10/22/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:BCR
• CIK: 9892
• Web: www.crbard.com
• Phone: +1-908-2778000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 21.91
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A